Mark Andreas Kluth
12PUBLICATIONS
38CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Aug 18, 2025
Dimethyl sulfoxide in cryopreserved mesenchymal stromal cell therapy products: is there a safety risk to patients?Elke Niebergall-Roth, Mark Andreas Kluth
|Nov 17, 2024
Systemic treatment of recessive dystrophic epidermolysis bullosa with mesenchymal stromal cells: a scoping review of the literature and conclusions for future clinical research.Elke Niebergall-Roth, Kathrin Dieter, Markus H Frank
|Sep 14, 2024
Anti-Inflammatory and Anti-(Lymph)angiogenic Properties of an ABCB5+ Limbal Mesenchymal Stem Cell Population.Berbang Meshko, Thomas L A Volatier, Johanna Mann
|Dec 23, 2023
Adipose-Derived Mesenchymal Stem Cells Protect Endothelial Cells from Hypoxic Injury by Suppressing Terminal UPR In Vivo and In Vitro.Michael Keese, Jiaxing Zheng, Kaixuan Yan
|Jul 14, 2023
ABCB5+ Limbal Epithelial Stem Cells Inhibit Developmental but Promote Inflammatory (Lymph) Angiogenesis While Preventing Corneal Inflammation.Berbang Meshko, Thomas L A Volatier, Karina Hadrian
|Jan 08, 2023
Skin-Derived ABCB5+ Mesenchymal Stem Cells for High-Medical-Need Inflammatory Diseases: From Discovery to Entering Clinical Routine.Elke Niebergall-Roth, Natasha Y Frank, Christoph Ganss
Pageof 2
Frequent Collaborators
6 joint publications
Markus H Frank
3 joint publications
Elke Niebergall-Roth
2 joint publications
Karen Bieback
2 joint publications
Kathrin Dieter
2 joint publications
Thomas L A Volatier
2 joint publications
Berbang Meshko
2 joint publications
Claus Cursiefen
2 joint publications
Christoph Ganss
1 joint publications
Korinna Kraft
1 joint publications
Markus Stücker
